Your browser doesn't support javascript.
loading
Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
Chen, Xinchang; Li, Rong; Ge, Shijia; Li, Yang; Cai, Cui; Weng, Taoping; Zhang, Yilin; Jiang, Jingwen; Feng, Zhen; Chen, Yuanyuan; Zhang, Yungui; Ma, Jian; Persing, David H; Chen, Jiazhen; Tang, Yi-Wei; Sun, Feng; Zhang, Wenhong.
Afiliação
  • Chen X; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li R; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Ge S; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li Y; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Cai C; Department of Tuberculosis, Guiyang Public Health Clinical Center, Guiyang, China.
  • Weng T; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang Y; Department of Respiratory Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Jiang J; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Feng Z; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Chen Y; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang Y; Zhejiang Prevention and Treatment Center of Tuberculosis, Zhejiang TCM & WM Hospital, Hangzhou, China.
  • Ma J; Department of Tuberculosis, Yunnan Provincial Infectious Diseases Hospital, Kunming, Yunan, China.
  • Persing DH; Medical Affairs, Danaher Diagnostic Platform/Cepheid, Shanghai, China.
  • Chen J; Medical Affairs, Danaher Diagnostic Platform/Cepheid, Shanghai, China.
  • Tang YW; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Sun F; Medical Affairs, Danaher Diagnostic Platform/Cepheid, Shanghai, China.
  • Zhang W; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
J Clin Microbiol ; 61(6): e0183222, 2023 06 20.
Article em En | MEDLINE | ID: mdl-37249422
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China